All sites C00-96,D32-33,D42-43,D45-47,D76 413 90.8 1.7 3.6 1.3 2.6
Mouth, pharynx C00-14 5 96.0 - 4.0 - -
  Lip C00 0 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 1 83.3 - 16.7 - -
  Pharynx C01,C09-14 0 100.0 - - - -
Digestive organs C15-26 76 83.1 2.4 9.2 2.9 2.4
  Oesophagus C15 2 90.0 - 10.0 - -
  Stomach C16 6 89.3 - 7.1 3.6 -
  Small intestine C17 1 83.3 - - - 16.7
  Colon C18 27 97.0 - 1.5 0.7 0.7
  Rectum, rectosigmoid C19-20 12 96.7 - - 3.3 -
  Anus C21 1 100.0 - - - -
  Liver C22 5 56.5 4.3 26.1 4.3 8.7
  Gallbladder, bile ducts C23-24 5 74.1 11.1 11.1 3.7 -
  Pancreas C25 16 58.5 6.1 23.2 6.1 6.1
  Other digestive organs C26 1 50.0 - 50.0 - -
Respiratory organs C30-39 22 80.7 4.6 8.3 0.9 5.5
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 21 81.7 4.8 7.7 1.0 4.8
  Mediastinum, pleura C38 0 - - - - 100.0
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 16 100.0 - - - -
Skin, non-melanoma C44 28 99.3 - - 0.7 -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 94.1 - - - 5.9
Breast C50 124 98.5 0.2 0.2 0.6 0.5
Female genital organs C51-58 44 99.5 - - - 0.5
  Cervix uteri C53 4 100.0 - - - -
  Corpus uteri C54 19 100.0 - - - -
  Uterus, other C55,C58 - - - - - -
  Ovary C56 15 98.7 - - - 1.3
  Other female genital C51-52,C57 5 100.0 - - - -
Urinary organs C64-68 23 91.4 - 4.3 - 4.3
  Kidney C64 14 86.8 - 5.9 - 7.4
  Bladder and urinary tract2 C65-68 10 97.9 - 2.1 - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 15 84.0 - 12.0 - 4.0
Thyroid gland C73 6 100.0 - - - -
Other endocrine glands C74-75 1 66.7 - 33.3 - -
Illdefined or unknown C76,C80 13 63.6 3.0 16.7 7.6 9.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 36 75.3 9.9 1.1 2.7 11.0
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 14 98.6 - - - 1.4
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 5 66.7 4.2 8.3 12.5 8.3
  Leukaemia C91-95 9 44.4 31.1 - 2.2 22.2
  Myelodysplastic syndromes D46 1 - 14.3 - - 85.7
  Myeloproliferaitive neoplasms D45,D47 5 84.6 7.7 - 3.8 3.8
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 9 100.0 - - - -
  Borderline tumour of the ovary D39 5 100.0 - - - -
  Basal cell carcinoma of the skin 87 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.